Great Pacific Gold Corp. Commences Drilling at Hampore Target in Papua New Guinea Project February 6, 2025 Vancouver, British Columbia– Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) (“Great Pacific Gold,” “GPAC,” or the “Company”) is pleased to announce that drilling has commenced at the high-priority Hampore target within the Kesar Project (“Kesar”…

Welcome to the Adventures of VR Resources Ltd! Exploring the Wild Frontiers of Northwestern Ontario By: Your Quirky and Curious Explorer Gather ’round, dear readers, as we embark on a journey to the untamed wilderness of northwestern Ontario with VR Resources Ltd, the daring explorers behind the Silverback and Empire projects. Picture this: vast forests…

Welcome to our Blog! Why Progressive Insurance is a Top Investment Pick Progressive is not only a well-known insurance company in the U.S., but it’s also one of the largest players in the market. Their business model, which heavily relies on online sales, has proven to be quite efficient and successful. What makes Progressive stand…

Class Action Lawsuit Filed Against Sun Communities, Inc. Bronstein, Gewirtz & Grossman, LLC Alerts Investors NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sun Communities, Inc. (“Sun Communities” or “the Company”)…

Exciting News for Shareholders! BREAKING: CMS Energy Raises Quarterly Dividend JACKSON, Mich., Feb. 6, 2025 /PRNewswire/ — The Board of Directors of CMS Energy today increased the quarterly dividend on the company’s common stock to 54.25 cents per share, up from 51.50 cents per share. Hey there, fellow investors! Have you heard the latest news?…

Shanghai Henlius Biotech, Inc. Announces License Agreement with Dr. Reddy’s Laboratories SA Overview On February 6, 2025, Shanghai Henlius Biotech, Inc. revealed a significant milestone by entering into a license agreement with Dr. Reddy’s Laboratories SA for the company’s daratumumab biosimilar, HLX15. This agreement marks a strategic partnership between the two pharmaceutical giants and underscores…